Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pooled RBCs for Transfusion
NCT03056378Phase 1Withdrawn
- Sponsor
- New York Blood Center
- Start
- Oct 2019
- Primary completion
- Dec 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pooled red blood cells in anemia (2 arms), sponsored by New York Blood Center. Primary endpoint: Quantitation of adverse events at 60 days. Planned start Oct 2019; status: withdrawn.
02
Drugs
pooled red blood cells
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03056378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03056378.